1. Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer. (February 2021) Authors: Rocca, Andrea; Cortesi, Pietro; Cortesi, Laura; Gianni, Lorenzo; Matteucci, Federica; Fantini, Lorenzo; Maestri, Antonio; Giunchi, Donata Casadei; Cavanna, Luigi; Ciani, Rosa; Falcini, Fabio; Bagni, Antonella; Meldoli, Elena; Dall'Agata, Monia; Volpi, Roberta; Andreis, Daniele; Nanni, Oriana; Cur... Journal: Therapeutic advances in medical oncology Issue: Volume 13(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗